富含半胱氨酸的酸性分泌糖蛋白在体外调节人平滑肌细胞动脉稳态的实验研究
[Abstract]:Objective: The intracranial aneurysm is a life-threatening disease. It is the primary cause of the spontaneous subarachnoid hemorrhage, and once the aneurysm ruptures, there is a very high rate of disability and mortality. The exact pathogenesis of the intracranial aneurysm is still not very clear, and the lack of screening for the occurrence of intracranial aneurysms and the assessment of specific biological markers for the risk of their rupture. According to the literature review, the research group put forward the concept of the "arterial steady state" Homeostat, that is, to the damage caused by the blood flow stress and the degeneration of the blood vessel, the arterial blood tube has the ability to repair itself, so that the dynamic balance of the injury and the repair is formed to maintain the blood vessel stability, The break in this balance may be the pathogenesis of an intracranial aneurysm. Genetic factors play an increasingly important role in the pathogenesis of intracranial aneurysms. It is shown that the acidic secreted glycoprotein (SPARC), which is rich in cysteine, is widely expressed in the smooth muscle cell layer of the intracranial aneurysm, and its effect on smooth muscle cells is not clear. The purpose of this paper is to study the effect of SPARC on the human vascular smooth muscle cells, and whether the effect of this effect on the steady state of the artery, thus to explore the possible role of SPARC in the occurrence and development of the intracranial aneurysm. Methods: The primary human umbilical artery smooth muscle cells (HUASMCs) were used as the research object, and the cells were exposed to a medium containing (0, 0.125, 0.25, 0.5,1,2 and 4 ug/ ml) for 24 hours, and the cell viability of HUASMCs was detected by a cell count kit (CCK8). The cell cycle distribution and cell apoptosis rate of HUASMCs were detected by flow cytometry after 2,6,12,24 and 48 hours of medium containing (0,2 ug/ ml) of SPARC, respectively. The expression of the following proteins in HUASMCs was detected by Western Blot technique: cell cycle control protein (P21, P53, CyclinD1), Apoptosis-related proteins (Bax, Bcl2, Caspase-3, Ceaved Caspase-3), gelatinase and metalloprotease inhibitor (MMP2, MMP9, TIMP2, TIMP1). Results: HUASMCs were exposed to a medium containing (2,4 ug/ ml) of SPARC, and after 24 hours, the cell viability was 89.30% and 87.57% 2.17%, respectively (P0.05 vs. control group). After 12 hours of exposure to a medium containing 2 ug/ ml of SPARC, the proportion of cells in the G0/ G1 phase of the cell cycle was 74.77 and 1.33% (P0.05 vs. The proportion of cells in early and late-stage apoptosis was 7.38-1.25% and 4.86-0.81%, respectively (P0.01 vs. control group). When HUASMCs were exposed to a medium containing 2 ug/ ml of SPARC for 24 hours, the results showed that the content of P21 protein increased significantly in 2-12 hours (P0.05 vs. control group), while the expression of P53 protein did not change significantly within 48 hours (P0.05 vs. control group); at the same time, The level of Bax protein was up-regulated and peaked at 24 h (P0.01 vs. control group), while the Bcl2 protein did not change significantly within 24 hours, but decreased significantly in 48 hours (P0.01 vs. control group), and Cleared casei 3 protein was also up-regulated and reached its peak at 24 h (P0.05 vs. control group); The content of MMP2 protein was significantly increased and reached the peak at 24 h (P0.01 vs. control group), and the expression level of TIMP2 protein was relatively stable; the expression of MMP9 protein was significantly increased, with a significant increase in the content of TIMP1 protein (P0.05 vs. Control group). The results suggest that SPARC can block the proliferation of HUASMCs by increasing the expression of P21 protein in the G0/ G1 phase of the cell cycle, inhibit the proliferation of the HUASMCs, and promote the apoptosis of the cells of the HUASMCs in the mitochondria pathway, thereby reducing the cell viability of the HUASMCs. SPARC may also promote the gelatinase (MMP2, The secretion of MMP9 leads to the degeneration of the extracellular matrix and the inner elastic layer in the vascular wall. Conclusion: The results suggest that SPARC may increase the damage to the media, inner elastic layer and other extracellular matrix of the intracranial artery, reduce its self-healing ability, break the dynamic balance of the arterial injury and repair, and result in the occurrence and development of the intracranial aneurysm. And even break.
【学位授予单位】:山东大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R743
【相似文献】
相关期刊论文 前10条
1 崔永,王天佑;SPARC与恶性肿瘤[J];中华医学杂志;2005年09期
2 张雪梅;陈嘉薇;胡宏慧;路光中;杨兆瑞;;乳腺浸润性导管癌组织中SPARC蛋白表达研究[J];上海交通大学学报(医学版);2008年11期
3 冯丹;蔡建;张颖一;卫子然;王雅杰;;SPARC在恶性肿瘤中的研究进展[J];医学研究杂志;2011年10期
4 冯丹;蔡建;张颖一;傅强;王雅杰;;SPARC结构与功能研究进展[J];现代生物医学进展;2012年03期
5 耿文君;;SPARC研究进展[J];生命科学仪器;2009年02期
6 罗盘;罗振;赵秀华;肖娜;程腊梅;;SPARC基因敲除小鼠的繁育及子代基因型的鉴定[J];现代生物医学进展;2010年03期
7 王文靖,梅长林,孙田美,汤兵,沈学飞,李占园;SPARC在常染色体显性多囊肾病患者体液中的表达及其分泌研究[J];解放军医学杂志;2005年04期
8 徐东旭;徐璐;李彦君;李朝辉;李智;滕月娥;;SPARC蛋白在乳腺癌组织中的表达及临床意义[J];中国医科大学学报;2014年06期
9 王毓林;SPARC与白内障[J];江西医学院学报;2003年01期
10 许东,韩昱晨;SPARC与肿瘤[J];日本医学介绍;2001年04期
相关会议论文 前6条
1 谢浩;张健;;星载SPARC V8嵌入式系统设计[A];2007'中国仪器仪表与测控技术交流大会论文集(二)[C];2007年
2 王文靖;梅长林;;SPARC对常染色体显性多囊肾病的作用研究[A];2007年浙沪两地肾脏病学术年会资料汇编[C];2007年
3 王文靖;梅长林;;SPARC对常染色体显性多囊肾病的作用研究[A];“中华医学会肾脏病学分会2004年年会”暨“第二届全国中青年肾脏病学术会议”论文汇编[C];2004年
4 王小霞;李志伟;张艳桥;;SPARC在胃癌中的表达及对胃癌生存的影响[A];第9届全国胃癌学术会议暨第二届阳光长城肿瘤学术会议论文汇编[C];2014年
5 Wu Xin-yi;Peng Xiao-hong;Hou Li-gang;He Ming;Wu Wu-chen;;A Design of Embedded Serial Communication Program Based on MiniGUI[A];Proceedings of 2011 International Conference on Computer Science and Information Technology(ICCSIT 2011)[C];2011年
6 李傲迪;曲秀娟;李智;曲晶磊;宋娜;马艳菊;刘云鹏;;SPARC抑制Bufalin对胃癌细胞敏感性的机制研究[A];中国肿瘤内科进展 中国肿瘤医师教育(2014)[C];2014年
相关重要报纸文章 前10条
1 电脑商报记者 刘一冰;富士通将重振SPARC服务器市场[N];电脑商报;2009年
2 本报记者 宋家雨;SPARC64 Ⅳ生命周期引人关注[N];网络世界;2007年
3 祁金华;Sun公司往何处去?[N];网络世界;2009年
4 ;SPARC IIIi性价比演义第一回 以一当十何其难分兵多路巧用心[N];中国电子报;2004年
5 ;SPARC IIIi性价比演义第二回 软件高效应用广 背靠大树好乘凉[N];中国电子报;2004年
6 祁萌;富士通Unix新品首登中国[N];电脑商报;2007年
7 齐文;富士通和SUN联手出新品[N];中国税务报;2007年
8 本报记者 宋家雨;SPARC持续发力 国产备份奋起直追[N];网络世界;2009年
9 刘辰;NGO影响住房保障[N];中国房地产报;2008年
10 ;SPARC Ⅲi性价比演义[N];中国电子报;2004年
相关博士学位论文 前5条
1 李波;SPARC在颅内动脉瘤表达的研究和FAP-1对胶质母细胞瘤活性侵袭迁移的影响[D];山东大学;2015年
2 罗振;SPARC对造血发育的影响及机理研究[D];中南大学;2013年
3 刘欣;去传入海马差异表达基因的筛选和SPARC表达[D];中国科学院研究生院(上海生命科学研究院);2005年
4 刘海燕;RNA干扰抑制SPARC表达对恶性胶质瘤生长和辐射敏感性的影响及其机制研究[D];苏州大学;2011年
5 毛正发;SPARC在胰腺癌中的作用及其增加化疗敏感性的机制[D];复旦大学;2011年
相关硕士学位论文 前10条
1 谢一泓;SPARC基因过表达对卵巢癌淋巴结高转移细胞生物学特性的影响[D];广西医科大学;2015年
2 何君芳;SPARC、P53和VEGF在脑胶质瘤中的蛋白表达及临床意义[D];兰州大学;2015年
3 华红伟;SPARC调节糖酵解影响肝癌细胞对5-FU敏感性的研究[D];上海交通大学;2014年
4 高永银;化疗对胃癌SPARC表达的影响及意义[D];天津医科大学;2015年
5 郑鹏凤;SPARC蛋白表达与白蛋白结合型紫杉醇治疗晚期NSCLC疗效的关系[D];山西医科大学;2016年
6 商立凤;SPARC微处理器在线故障检测技术[D];哈尔滨工业大学;2016年
7 朱蕴中;面向SPARC V8 ISA的处理器模型验证技术研究[D];哈尔滨工业大学;2016年
8 李涛;基于SPARC V8的虚拟仿真平台的设计与实现[D];哈尔滨工业大学;2016年
9 项文成;通用嵌入式虚拟验证系统中SPARC V8仿真核的设计与实现[D];哈尔滨工业大学;2016年
10 叶耿帆;富含半胱氨酸的酸性分泌糖蛋白在体外调节人平滑肌细胞动脉稳态的实验研究[D];山东大学;2017年
,本文编号:2492967
本文链接:https://www.wllwen.com/yixuelunwen/shenjingyixue/2492967.html